These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30365309)

  • 1. Structural Basis for ( S)-3,4-Dicarboxyphenylglycine (DCPG) As a Potent and Subtype Selective Agonist of the mGlu
    Chen Q; Ho JD; Ashok S; Vargas MC; Wang J; Atwell S; Bures M; Schkeryantz JM; Monn JA; Hao J
    J Med Chem; 2018 Nov; 61(22):10040-10052. PubMed ID: 30365309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord.
    Thomas NK; Wright RA; Howson PA; Kingston AE; Schoepp DD; Jane DE
    Neuropharmacology; 2001 Mar; 40(3):311-8. PubMed ID: 11166323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of the potent mGlu8 receptor agonist (S)-3,4-DCPG induces c-Fos in stress-related brain regions in wild-type, but not mGlu8 receptor knockout mice.
    Linden AM; Bergeron M; Baez M; Schoepp DD
    Neuropharmacology; 2003 Sep; 45(4):473-83. PubMed ID: 12907308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective agonism of mGlu8 receptors by (S)-3,4-dicarboxyphenylglycine does not affect sleep stages in the rat.
    Cavas M; Scesa G; Martín-López M; Navarro JF
    Pharmacol Rep; 2017 Feb; 69(1):97-104. PubMed ID: 27914294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of L-AP4-bound human mGlu8 receptor amino terminal domain structure and the molecular basis for L-AP4's group III mGlu receptor functional potency and selectivity.
    Schkeryantz JM; Chen Q; Ho JD; Atwell S; Zhang A; Vargas MC; Wang J; Monn JA; Hao J
    Bioorg Med Chem Lett; 2018 Feb; 28(4):612-617. PubMed ID: 29402739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of excitatory transmission in the retino-collicular pathway via selective activation of mGlu8 receptors by DCPG.
    Pothecary CA; Jane DE; Salt TE
    Neuropharmacology; 2002 Aug; 43(2):231-4. PubMed ID: 12213277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of the antianxiety-like effect of (S)-3,4-DCPG, an mGlu8 receptor agonist, after central administration in rats.
    Stachowicz K; Kłak K; Pilc A; Chojnacka-Wójcik E
    Pharmacol Rep; 2005; 57(6):856-60. PubMed ID: 16382208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice.
    Marabese I; de Novellis V; Palazzo E; Scafuro MA; Vita D; Rossi F; Maione S
    Neuropharmacology; 2007 Feb; 52(2):253-62. PubMed ID: 17113112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-3,4-DCPG, a potent orthosteric agonist for the mGlu8 receptor, facilitates extinction and inhibits the reinstatement of morphine-induced conditioned place preference in male rats.
    Kahvandi N; Ebrahimi Z; Sharifi M; Karimi SA; Shahidi S; Salehi I; Haddadi R; Sarihi A
    Pharmacol Biochem Behav; 2024 Jul; 240():173772. PubMed ID: 38653345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the Structural Aspects of the mGlu Receptor Orthosteric Binding Site.
    Hao J; Chen Q
    Curr Top Med Chem; 2019; 19(26):2421-2446. PubMed ID: 31660833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles of mGlu8 receptors in the regulation of glutamate and gamma-aminobutyric acid release at periaqueductal grey level.
    Marabese I; de Novellis V; Palazzo E; Mariani L; Siniscalco D; Rodella L; Rossi F; Maione S
    Neuropharmacology; 2005; 49 Suppl 1():157-66. PubMed ID: 16084932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease.
    Johnson KA; Jones CK; Tantawy MN; Bubser M; Marvanova M; Ansari MS; Baldwin RM; Conn PJ; Niswender CM
    Neuropharmacology; 2013 Mar; 66():187-95. PubMed ID: 22546615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsive effect of a selective mGluR8 agonist (S)-3,4-dicarboxyphenylglycine (S-3,4-DCPG) in the mouse pilocarpine model of status epilepticus.
    Jiang FL; Tang YC; Chia SC; Jay TM; Tang FR
    Epilepsia; 2007 Apr; 48(4):783-92. PubMed ID: 17430409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of an mGlu8 receptor-selective agonist and antagonist in the lateral and medial perforant path inputs to the dentate gyrus.
    Mercier MS; Lodge D; Fang G; Nicolas CS; Collett VJ; Jane DE; Collingridge GL; Bortolotto ZA
    Neuropharmacology; 2013 Apr; 67():294-303. PubMed ID: 23220400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia.
    Robbins MJ; Starr KR; Honey A; Soffin EM; Rourke C; Jones GA; Kelly FM; Strum J; Melarange RA; Harris AJ; Rocheville M; Rupniak T; Murdock PR; Jones DN; Kew JN; Maycox PR
    Brain Res; 2007 Jun; 1152():215-27. PubMed ID: 17434465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions of Group I and Group II metabotropic glutamate receptor ligands on 5-hydroxytryptamine release in the rat cerebral cortex in vivo: differential roles in the regulation of central serotonergic neurotransmission.
    Lee JJ; Croucher MJ
    Neuroscience; 2003; 117(3):671-9. PubMed ID: 12617971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG.
    Bäckström P; Hyytiä P
    Eur J Pharmacol; 2005 Dec; 528(1-3):110-8. PubMed ID: 16324694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural profile of selective ligands for mGlu7 and mGlu8 glutamate receptors in agonistic encounters between mice.
    Navarro JF; de Castro V; Martín-López M
    Psicothema; 2009 Aug; 21(3):475-9. PubMed ID: 19622332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino-pyrrolidine tricarboxylic acids give new insight into group III metabotropic glutamate receptor activation mechanism.
    Frauli M; Hubert N; Schann S; Triballeau N; Bertrand HO; Acher F; Neuville P; Pin JP; Prézeau L
    Mol Pharmacol; 2007 Mar; 71(3):704-12. PubMed ID: 17167031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice.
    Moldrich RX; Beart PM; Jane DE; Chapman AG; Meldrum BS
    Neuropharmacology; 2001 Apr; 40(5):732-5. PubMed ID: 11311902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.